A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

NATerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 17, 2017

Primary Completion Date

July 15, 2019

Study Completion Date

April 24, 2020

Conditions
HCCLiver Cancer
Interventions
RADIATION

MRI and HIDA scan

Pre y90 therapy each subject will undergo a HIDA and MRI scan. 3 months post Y90 - Each subject will undergo a second HIDA scan and MRI scan

Trial Locations (1)

46202

Indiana University Hospital, Indianapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Indiana University

OTHER